SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.165-2.3%10:58 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ChinuSFO who started this subject7/19/2001 2:50:48 PM
From: gao seng  Read Replies (1) of 645
 
14:39 ET Aviron (AVIR) 38.00 -4.01 (-9.5%): -- Update -- Morgan Stanley out in defense of stock against concerns about the "surly" FDA environment and the company's 1998 healthy adult FluMist clinical trial not meeting it primary endpoint; firm continues to believe odds favor FluMist at next week's FDA advisory panel meeting; would take advantage of weakness to be aggressive buyers.

14:28 ET Aviron (AVIR) 37.97 -4.04 (-9.6%): -- Update -- Morgan Stanley out in defense after hurt on concerns of FDA timeline delays; firm points out that American Home Products (AHP) signed on as partner after learning of the data that supposedly has been called into question.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News